The COVID-19 pandemic has grown into a health crisis with unique risks that are disrupting business operations and leaving public companies with many questions. While “known unknowns” need to be understood and managed, it is the “unknown unknowns” that need to be surfaced and considered.
We have set out 51 issues we have been addressing for Canadian public companies concerning the impact of COVID-19 on their financial results, operations and cash flows, as well as the price or value of their securities in public capital markets.
View the full checklist here.
Many of the issues listed have been referenced in recent Blakes Bulletins, while others will be addressed in further, pending publications. For more information on any of these matters, please get in touch with your usual Blakes contact or any member of our Capital Markets group.
Blakes and Blakes Business Class communications are intended for informational purposes only and do not constitute legal advice or an opinion on any issue. We would be pleased to provide additional details or advice about specific situations if desired.
For permission to republish this content, please contact the Blakes Client Relations & Marketing Department at [email protected].
© 2024 Blake, Cassels & Graydon LLP